• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型含芳基哌嗪部分的异恶唑衍生物的合成及细胞生物活性作为抗癌剂。

Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents.

机构信息

a Department of Pharmaceutical Chemistry, Faculty of Pharmacy , Gazi University , Ankara , Turkey.

b Department of Bioinformatics , Middle East Technical University , Ankara , Turkey.

出版信息

J Enzyme Inhib Med Chem. 2018 Dec;33(1):1352-1361. doi: 10.1080/14756366.2018.1504041.

DOI:10.1080/14756366.2018.1504041
PMID:30251900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6161610/
Abstract

In our endeavour towards the development of effective anticancer therapeutics, a novel series of isoxazole-piperazine hybrids were synthesized and evaluated for their cytotoxic activities against human liver (Huh7 and Mahlavu) and breast (MCF-7) cancer cell lines. Within series, compounds 5l-o showed the most potent cytotoxicity on all cell lines with IC values in the range of 0.3-3.7 μM. To explore the mechanistic aspects fundamental to the observed activity, further biological studies with 5m and 5o in liver cancer cells were carried out. We have demonstrated that 5m and 5o induce oxidative stress in PTEN adequate Huh7 and PTEN deficient Mahlavu human liver cancer cells leading to apoptosis and cell cycle arrest at different phases. Further analysis of the proteins involved in apoptosis and cell cycle revealed that 5m and 5o caused an inhibition of cell survival pathway through Akt hyperphosphorylation and apoptosis and cell cycle arrest through p53 protein activation.

摘要

在开发有效抗癌疗法的努力中,我们合成了一系列新型异恶唑-哌嗪杂合体,并评估了它们对人肝癌(Huh7 和 Mahlavu)和乳腺癌(MCF-7)癌细胞系的细胞毒性。在该系列中,化合物 5l-o 对所有细胞系表现出最强的细胞毒性,IC 值范围为 0.3-3.7 μM。为了探索与观察到的活性相关的机制方面,我们在肝癌细胞中进一步进行了 5m 和 5o 的生物学研究。我们已经证明,5m 和 5o 在 PTEN 充分的 Huh7 和 PTEN 缺乏的 Mahlavu 人肝癌细胞中诱导氧化应激,导致细胞凋亡和细胞周期阻滞在不同阶段。对参与细胞凋亡和细胞周期的蛋白质的进一步分析表明,5m 和 5o 通过 Akt 过度磷酸化抑制细胞存活途径,并通过 p53 蛋白激活导致细胞凋亡和细胞周期阻滞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a1/6161610/fbfa371ad82a/IENZ_A_1504041_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a1/6161610/a75decfb4ad0/IENZ_A_1504041_SCH0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a1/6161610/73e40771c865/IENZ_A_1504041_SCH0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a1/6161610/b8d0989af757/IENZ_A_1504041_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a1/6161610/294c701c96a6/IENZ_A_1504041_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a1/6161610/01227c600285/IENZ_A_1504041_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a1/6161610/fbfa371ad82a/IENZ_A_1504041_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a1/6161610/a75decfb4ad0/IENZ_A_1504041_SCH0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a1/6161610/73e40771c865/IENZ_A_1504041_SCH0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a1/6161610/b8d0989af757/IENZ_A_1504041_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a1/6161610/294c701c96a6/IENZ_A_1504041_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a1/6161610/01227c600285/IENZ_A_1504041_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a1/6161610/fbfa371ad82a/IENZ_A_1504041_F0004_C.jpg

相似文献

1
Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents.新型含芳基哌嗪部分的异恶唑衍生物的合成及细胞生物活性作为抗癌剂。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):1352-1361. doi: 10.1080/14756366.2018.1504041.
2
Synthesis and biological evaluation of novel isoxazole-piperazine hybrids as potential anti-cancer agents with inhibitory effect on liver cancer stem cells.新型异噁唑-哌嗪杂合体的合成及生物评价作为潜在的肝癌干细胞抑制活性的抗癌剂。
Eur J Med Chem. 2021 Oct 5;221:113489. doi: 10.1016/j.ejmech.2021.113489. Epub 2021 Apr 24.
3
Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.3,5-二芳基异恶唑啉/异恶唑并[2,3-a]喹唑啉酮类化合物的合成及生物活性评价。
Eur J Med Chem. 2011 Feb;46(2):691-703. doi: 10.1016/j.ejmech.2010.12.004. Epub 2010 Dec 14.
4
Synthesis and anticancer activity evaluation of some benzothiazole-piperazine derivatives.某些苯并噻唑 - 哌嗪衍生物的合成与抗癌活性评估
Anticancer Agents Med Chem. 2015;15(3):382-9. doi: 10.2174/1871520615666141216151101.
5
Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents.新型异恶唑基查尔酮作为潜在抗癌剂的合成与评价
Bioorg Chem. 2014 Jun;54:38-43. doi: 10.1016/j.bioorg.2014.03.004. Epub 2014 Mar 15.
6
Synthesis of some novel methyl β-orsellinate based 3, 5-disubstituted isoxazoles and their anti-proliferative activity: Identification of potent leads active against MCF-7 breast cancer cell.合成一些新型的基于甲基 β-orsellinate 的 3,5-二取代异恶唑类化合物及其抗增殖活性:鉴定对 MCF-7 乳腺癌细胞有活性的有效先导化合物。
Bioorg Chem. 2020 Dec;105:104374. doi: 10.1016/j.bioorg.2020.104374. Epub 2020 Oct 13.
7
Synthesis of novel forskolin isoxazole derivatives with potent anti-cancer activity against breast cancer cell lines.具有针对乳腺癌细胞系的强效抗癌活性的新型福司可林异恶唑衍生物的合成。
Bioorg Med Chem Lett. 2017 Sep 15;27(18):4314-4318. doi: 10.1016/j.bmcl.2017.08.033. Epub 2017 Aug 16.
8
Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents.新型海洋溴代吡咯生物碱类 hybrids 的合成与评价及其作为抗癌剂的应用。
Eur J Med Chem. 2013 May;63:793-9. doi: 10.1016/j.ejmech.2013.03.029. Epub 2013 Mar 26.
9
Synthesis, biological evaluation and SAR of naftopidil-based arylpiperazine derivatives.基于萘哌地尔的芳基哌嗪衍生物的合成、生物学评价及构效关系研究
Bioorg Med Chem Lett. 2018 May 15;28(9):1534-1539. doi: 10.1016/j.bmcl.2018.03.070. Epub 2018 Mar 26.
10
Antiproliferative novel isoxazoles: modeling, virtual screening, synthesis, and bioactivity evaluation.抗增殖新型异恶唑类化合物:建模、虚拟筛选、合成及生物活性评价
Eur J Med Chem. 2014 Jun 23;81:139-49. doi: 10.1016/j.ejmech.2014.05.011. Epub 2014 May 4.

引用本文的文献

1
New Triazole-Isoxazole Hybrids as Antibacterial Agents: Design, Synthesis, Characterization, In Vitro, and In Silico Studies.新型三唑-异噁唑杂合体作为抗菌剂:设计、合成、表征、体外和计算研究。
Molecules. 2024 May 26;29(11):2510. doi: 10.3390/molecules29112510.
2
Heterocyclic Compounds as Hsp90 Inhibitors: A Perspective on Anticancer Applications.作为Hsp90抑制剂的杂环化合物:抗癌应用前景
Pharmaceutics. 2022 Oct 18;14(10):2220. doi: 10.3390/pharmaceutics14102220.
3
New Oxazolo[5,4-]pyrimidines as Potential Anticancer Agents: Their Design, Synthesis, and In Vitro Biological Activity Research.

本文引用的文献

1
Leflunomide: A promising drug with good antitumor potential.来氟米特:一种具有良好抗肿瘤潜力的有前景的药物。
Biochem Biophys Res Commun. 2018 Feb 5;496(2):726-730. doi: 10.1016/j.bbrc.2018.01.107.
2
Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma.regorafenib和sorafenib在肝细胞癌临床前模型中的抗肿瘤作用。
Oncotarget. 2017 Nov 6;8(63):107096-107108. doi: 10.18632/oncotarget.22334. eCollection 2017 Dec 5.
3
Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non-Small Cell Lung Cancer.
新型[5,4-]噁唑并嘧啶类化合物作为潜在的抗癌药物:设计、合成及体外生物活性研究。
Int J Mol Sci. 2022 Oct 2;23(19):11694. doi: 10.3390/ijms231911694.
4
Tyrosol Derivatives, Bearing 3,5-Disubstituted Isoxazole and 1,4-Disubstituted Triazole, as Potential Antileukemia Agents by Promoting Apoptosis.没食子醇衍生物,具有 3,5-二取代异恶唑和 1,4-二取代三唑结构,可通过促进细胞凋亡发挥潜在的抗白血病作用。
Molecules. 2022 Aug 10;27(16):5086. doi: 10.3390/molecules27165086.
5
Synthesis of novel isoxazole-carboxamide derivatives as promising agents for melanoma and targeted nano-emulgel conjugate for improved cellular permeability.新型异恶唑-羧酰胺衍生物的合成作为有前景的黑色素瘤治疗药物以及用于改善细胞通透性的靶向纳米乳凝胶缀合物。
BMC Chem. 2022 Jun 24;16(1):47. doi: 10.1186/s13065-022-00839-5.
6
Preclinical Study of Immunological Isoxazole Derivatives as a Potential Support for Melanoma Chemotherapy.免疫异恶唑衍生物作为一种潜在的黑色素瘤化疗辅助药物的临床前研究。
Int J Mol Sci. 2021 Oct 10;22(20):10920. doi: 10.3390/ijms222010920.
7
Progress in Redirecting Antiparasitic Drugs for Cancer Treatment.抗寄生虫药物在癌症治疗中的新进展。
Drug Des Devel Ther. 2021 Jun 22;15:2747-2767. doi: 10.2147/DDDT.S308973. eCollection 2021.
8
Synthesis and Biological Evaluation of Novel Isoxazole-Amide Analogues as Anticancer and Antioxidant Agents.新型异噁唑酰胺类似物的合成及抗癌抗氧化活性评价。
Biomed Res Int. 2021 Mar 9;2021:6633297. doi: 10.1155/2021/6633297. eCollection 2021.
9
Designing of Chitosan Derivatives Nanoparticles with Antiangiogenic Effect for Cancer Therapy.设计具有抗血管生成作用的壳聚糖衍生物纳米颗粒用于癌症治疗。
Nanomaterials (Basel). 2020 Apr 7;10(4):698. doi: 10.3390/nano10040698.
10
Antimicrobial, Antioxidant, and Anticancer Activities of Some Novel Isoxazole Ring Containing Chalcone and Dihydropyrazole Derivatives.某些含异恶唑环的查尔酮和二氢吡唑衍生物的抗菌、抗氧化和抗癌活性
Molecules. 2020 Feb 26;25(5):1047. doi: 10.3390/molecules25051047.
AUY922 治疗既往治疗和分子定义的晚期非小细胞肺癌患者的 HSP-90 抑制剂的 2 期研究。
J Thorac Oncol. 2018 Apr;13(4):576-584. doi: 10.1016/j.jtho.2017.11.131. Epub 2017 Dec 13.
4
Synthesis and Antitumor Activity of Novel Arylpiperazine Derivatives Containing the Saccharin Moiety.含糖精部分的新型芳基哌嗪衍生物的合成及抗肿瘤活性。
Molecules. 2017 Oct 29;22(11):1857. doi: 10.3390/molecules22111857.
5
Structure-Activity Relationships of New Natural Product-Based Diaryloxazoles with Selective Activity against Androgen Receptor-Positive Breast Cancer Cells.基于新天然产物的二芳基恶唑类化合物对雄激素受体阳性乳腺癌细胞的选择性活性构效关系
J Med Chem. 2017 Nov 22;60(22):9275-9289. doi: 10.1021/acs.jmedchem.7b01228. Epub 2017 Nov 3.
6
Isoxazole ring as a useful scaffold in a search for new therapeutic agents.异恶唑环作为一种有用的骨架,用于寻找新的治疗剂。
Eur J Med Chem. 2017 Sep 8;137:292-309. doi: 10.1016/j.ejmech.2017.06.002. Epub 2017 Jun 2.
7
ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway.代谢应激下的ROS信号传导:AMPK与AKT途径之间的相互作用
Mol Cancer. 2017 Apr 13;16(1):79. doi: 10.1186/s12943-017-0648-1.
8
Piperazine derivatives for therapeutic use: a patent review (2010-present).用于治疗用途的哌嗪衍生物:专利综述(2010年至今)
Expert Opin Ther Pat. 2016 Jul;26(7):777-97. doi: 10.1080/13543776.2016.1189902. Epub 2016 May 31.
9
4,5-Diarylisoxazol-3-carboxylic acids: A new class of leukotriene biosynthesis inhibitors potentially targeting 5-lipoxygenase-activating protein (FLAP).4,5-二芳基异恶唑-3-羧酸:一类新型的白三烯生物合成抑制剂,可能靶向5-脂氧合酶激活蛋白(FLAP)。
Eur J Med Chem. 2016 May 4;113:1-10. doi: 10.1016/j.ejmech.2016.02.027. Epub 2016 Feb 15.
10
Liver cancer cells are sensitive to Lanatoside C induced cell death independent of their PTEN status.肝癌细胞对 Lanatoside C 诱导的细胞死亡敏感,与它们的 PTEN 状态无关。
Phytomedicine. 2016 Jan 15;23(1):42-51. doi: 10.1016/j.phymed.2015.11.012. Epub 2015 Dec 12.